rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    MBOT
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Citizens lowers Microbot Medical stock price target on weak Q3 results
      Nov 17Investing.comMBOT
      Microbot Medical earnings missed, revenue fell short of estimates
      Nov 17Investing.comMBOT
      Microbot Medical Inc. (MBOT) Reports Q3 Loss, Misses Revenue Estimates
      Nov 13Yahoo FinanceMBOT
      Microbot Medical® Strengthens IP Portfolio as it Continues to Establish Infrastructure to Support Future Commercialization Expansion
      Nov 5Yahoo FinanceMBOT
      Microbot Medical (MBOT) Stock Sees Fair Value Cut As Liberty Adoption Outlook Softens

      The fair value estimate for Microbot Medical has been reduced from US$6.33 to about US$5.38, a move that reflects a roughly 15% cut to the price target. Recent analyst commentary ties this shift to a more cautious view on how quickly hospitals may adopt the Liberty system and convert early interest into recurring orders. As you read on, you will see how these updated assumptions shape the evolving Microbot Medical story and what to watch next. Stay updated as the Fair Value for Microbot...

      Nov 3Yahoo FinanceMBOT
      Microbot Medical secures first office-based lab customer
      Oct 27Investing.comMBOT
      Microbot Medical® Secures its First Office-Based Lab (OBL) Customer for the LIBERTY® Endovascular Robotic System

      ELMNT IR also became the first account on the West Coast, marking a geographic expansion which aligns with the Company’s Full Market Release strategy. The Company believes the OBLs represent a rapidly growing healthcare segment and opportunity as many endovascular procedures are being done outside traditional hospital settings and Ambulatory Surgery Centers. HINGHAM, Mass., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY

      Oct 27Yahoo FinanceMBOT
      Microbot Medical Targets Endovascular Robotics Growth at SIR EDGE

      Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.

      Oct 24The Globe and MailMBOT
      Microbot Medical executives to attend SIR EDGE conference
      Oct 23Investing.comMBOT
      Microbot Medical® Attending Key Medical Conference to Engage with Decision-makers as it Continues to Expand Presence Across the U.S.
      Oct 23Yahoo FinanceMBOT
      Citizens initiates Microbot Medical stock with outperform rating
      Oct 23Investing.comMBOT
      Microbot Medical stock price target maintained at $12 by H.C. Wainwright
      Oct 21Investing.comMBOT
      Microbot Medical® Granted Multiple New Patents, Further Strengthening Its Global Intellectual Property Portfolio
      Oct 20Yahoo FinanceMBOT
      Microbot Medical Secures Israeli Distribution Deal for LIBERTY

      Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.

      Oct 7The Globe and MailMBOT
      Microbot Medical signs distribution deal for Israel market
      Oct 6Investing.comMBOT
      Microbot Medical® and Medtechnica Ltd. Enter into Three-Year Exclusive Distribution Agreement in Israel
      Oct 6Yahoo FinanceMBOT
      Microbot Medical® Highlights Growth Strategy
      Sep 25Yahoo FinanceMBOT
      Microbot Medical More Than Doubled Sales In Q2 Following LIBERTY Surgical Robot Launch – And It’s Expandi
      Sep 15BenzingaMBOT
      Fresh Off Commercialization Of Its Surgical Robot, Microbot Medical® Chief Discusses Product Traction And

      This post contains sponsored content and was created in collaboration with a third-party partner. Benzinga is a publisher and does not provide personalized investment advice or act as a broker or dealer. This content is

      Sep 15BenzingaMBOT
      Analysts Offer Insights on Healthcare Companies: Microbot Medical (MBOT) and Replimune Group (REPL)

      Detailed price information for Replimune Group Inc (REPL-Q) from The Globe and Mail including charting and trades.

      Sep 12The Globe and MailMBOT

      This is the newest page. Registered accounts read further back.